Corrigendum to “Brief international cognitive assessment for multiple sclerosis (BICAMS): A Danish validation study of sensitivity in early stages of MS” [Multiple Sclerosis and Related Disorders 37 (2020) 101458]

The authors regret that there are 2 errors in the published article:1)in table 1 data from MS and control group respectively have been switched on the 3 parameters: 25FWT, 9-HPT and LVCA;2)in table 2 one line concerning follow-up is placed in the wrong column for all 3 tests. The authors would like to apologise for any inconvenience caused. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MSMultiple Sclerosis and Related DisordersVol. 37PreviewMultiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system (Thompson, 2018). In Denmark the prevalence of MS is among the highest in the world with approximately 300 per 100.000 citizens being affected (Koch-Henriksen et al., 2018). MS is associated with a range of physical, psy-chiatric and cognitive symptoms. A large proportion of people with MS (pwMS) (40–75%) have cognitive im-pairment, primarily reduced information processing speed, memory and executive functions, and these symptoms may appear already in the early course of the disease (Trenova et al., 2016; Filippi et al., 2018). Full-Text PDF